Receipt of guideline-concordant treatment is associated with improved survival among patients with endometrial cancer, and racial and ethnic disparities in receipt of guideline-concordant care are well established. However, the extent to which guideline-concordant treatment disparities contribute to racial and et...
Ashley S. Felix, Simran A. Kanal, Caitlin E. Meade et al.· Cancer Epidemiology, Biomark...· 0 citations
Background: Guideline-concordant treatment (GCT) is a key indicator of cancer care quality, yet most studies rely on cancer registry data, which incompletely capture treatment adequacy and vary in population composition. As a result, estimates of racial and ethnic disparities in GCT may differ depending on treatment me...
Ashley S. Felix, Caitlin E. Meade, Simran A. Kanal et al.· Cancer Epidemiology, Biomark...· 0 citations
OBJECTIVES
Clinical trials are essential to therapeutic advancement, yet access to trials in ovarian cancer may not be equitably distributed. This study evaluated associations between community-level social vulnerability and county-level availability of interventional ovarian cancer clinical trials in the United States...
Reed M. O'Connor, Jennifer A. Sinnott, Caitlin E. Meade et al.· Gynecologic Oncology· 0 citations
It is suggested that digital inequities may contribute to site- and age-specific disparities in gynecologic cancer survival, underscoring the need to address barriers to digital access as part of efforts to improve cancer outcomes.
Julia Chalif, Laura M. Chambers, Caitlin E. Meade et al.· International Journal of Gyn...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.